000 | 01225 a2200313 4500 | ||
---|---|---|---|
005 | 20250516204211.0 | ||
264 | 0 | _c20150413 | |
008 | 201504s 0 0 eng d | ||
022 | _a1592-8721 | ||
024 | 7 |
_a10.3324/haematol.2013.099663 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTong, Wing H | |
245 | 0 | 0 |
_aDesensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase. _h[electronic resource] |
260 |
_bHaematologica _cJul 2014 |
||
300 |
_ae102-4 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibodies _ximmunology |
650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
650 | 0 | 4 | _aDesensitization, Immunologic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity _xcomplications |
650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xcomplications |
700 | 1 | _aPieters, Rob | |
700 | 1 | _aTissing, Wim J E | |
700 | 1 | _avan der Sluis, Inge M | |
773 | 0 |
_tHaematologica _gvol. 99 _gno. 7 _gp. e102-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.2013.099663 _zAvailable from publisher's website |
999 |
_c23689579 _d23689579 |